Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Locomotor sensitization to cocaine is associated with distinct pattern of glutamate receptor trafficking to the postsynaptic density in prefrontal cortex: early versus late withdrawal effects.

Pharmacology, biochemistry, and behavior | 2009

Glutamatergic neurotransmission plays an important role in the behavioral and molecular plasticity observed in cocaine mediated locomotor sensitization. Recent studies show that glutamatergic signaling is regulated by receptor trafficking, synaptic localization, and association with scaffolding proteins. The trafficking of the glutamate receptors was investigated in the dorsal and ventral prefrontal cortex at 1 and 21 days after repeated cocaine administration which produced robust locomotor sensitization. A subcellular fractionation technique was used to isolate the cellular synaptosomal fraction containing the postsynaptic density. At early withdrawal, the prefrontal cortex displayed a reduction in the synaptosomal content of the AMPA and NMDA receptor subunits. In contrast, after extended withdrawal, there was a significant increase in the trafficking of the receptors into the synaptosomal compartment. These changes were accompanied by corresponding trafficking of the postsynaptic glutamatergic scaffolding proteins. Thus, enhanced trafficking of glutamate receptors from cytosolic to synaptosomal compartment is associated with prolonged withdrawal from repeated exposure to cocaine and may have functional consequences for the synaptic and behavioral plasticity.

Pubmed ID: 19135470 RIS Download

Associated grants

  • Agency: NIDA NIH HHS, United States
    Id: DA14328

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


NR2B glutamate receptor (antibody)

RRID:AB_10671944

This monoclonal targets NR2B glutamate receptor

View all literature mentions

PICK1 scaffold protein (antibody)

RRID:AB_10672986

This monoclonal targets PICK1 scaffold protein

View all literature mentions

Anti-GluA2/GluR2 Glutamate Receptor Antibody (antibody)

RRID:AB_10674575

This monoclonal targets GluR2 glutamate receptor Gs protein alpha subunit

View all literature mentions

Anti-PSD-95 Antibody (antibody)

RRID:AB_10698024

This monoclonal targets PSD-95 MAGUK scaffolding protein

View all literature mentions

Anti-PICK1 Antibody (antibody)

RRID:AB_2164544

This monoclonal targets PICK1

View all literature mentions

Anti-GluA2/GluR2 Glutamate Receptor Antibody (antibody)

RRID:AB_2232661

This monoclonal targets GluA2/GluR2 glutamate receptor

View all literature mentions